Pioglitazone Completed Phase 2 Trials for Endobronchial Dysplasia / Lung Cancers Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT00780234Pioglitazone for Lung Cancer Chemoprevention